Retatrutide is a next-generation triple-agonist peptide (GLP-1, GIP, glucagon) for weight management delivered in a prefilled pen. Strong preclinical and early-clinical weight-loss profile with simplified once-weekly dosing.
Category
Purity
Primary Research Areas
Weight management, metabolic health, appetite regulation, body composition
By proceeding, you agree to our Terms of Service and acknowledge our Research Use Policy. peptide+ reserves the right to refuse service to any individual or entity suspected of misuse.